USDA Approves Corn Amylase Trait for Enogen™

BASEL, Switzerland, Feb. 11, 2011 /PRNewswire/ -- Syngenta announced today it has received full deregulation for its corn amylase trait from the U.S. Department of Agriculture (USDA). This is the first genetically modified output trait in corn for the ethanol industry. By enabling expression of an optimized alpha-amylase enzyme directly in corn, dry grind ethanol production can be improved in a way that can be easily integrated into existing infrastructure. Syngenta will sell corn seed with the amylase trait as Enogen corn seed.

"Enogen corn seed offers growers an opportunity to cultivate a premium specialty crop. It is a breakthrough product that provides U.S. ethanol producers with a proven means to generate more gallons of ethanol from their existing facilities," said Davor Pisk, Chief Operating Officer. "Enogen corn also reduces the energy and water consumed in the production process while substantially reducing carbon emissions."

Enogen corn seed will be available from the coming growing season. This year, Syngenta plans to work with a small number of ethanol plants and corn growers in close proximity and prepare for larger scale commercial introduction in 2012.  Production of Enogen corn will be managed by Syngenta using a contracted, closed production system.

The corn amylase trait in Enogen has already been approved for import into Australia, Canada, Japan, Mexico, New Zealand, Philippines, Russia and Taiwan, and for cultivation in Canada.

Syngenta is one of the world's leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life.  For more information about us please go to www.syngenta.com.

Enogen™ and the Syngenta logo are trademarks of a Syngenta Group Company.

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

SOURCE Syngenta